The emerging roles of TCF4 in disease and development

Marc P. Forrest, Matthew J. Hill, Andrew J. Quantock, Enca Martin-Rendon, Derek J. Blake*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

127 Scopus citations

Abstract

Genome-wide association studies have identified common variants in transcription factor 4 (TCF4) as susceptibility loci for schizophrenia, Fuchs' endothelial corneal dystrophy, and primary sclerosing cholangitis. By contrast, rare TCF4 mutations cause Pitt-Hopkins syndrome, a disorder characterized by intellectual disability and developmental delay, and have also been described in patients with other neurodevelopmental disorders. TCF4 therefore sits at the nexus between common and rare disorders. TCF4 interacts with other basic helix-loop-helix proteins, forming transcriptional networks that regulate the differentiation of several distinct cell types. Here, we review the role of TCF4 in these seemingly diverse disorders and discuss recent data implicating TCF4 as an important regulator of neurodevelopment and epithelial-mesenchymal transition.

Original languageEnglish (US)
Pages (from-to)322-331
Number of pages10
JournalTrends in Molecular Medicine
Volume20
Issue number6
DOIs
StatePublished - Jun 2014

Funding

This work was funded by a Medical Research Council (MRC) studentship (M.P.F.) and an MRC Centenary Award (D.J.B., M.P.F.).

Keywords

  • Epithelial-mesenchymal transition
  • Fuchs' endothelial corneal dystrophy
  • Intellectual disability
  • Pitt-Hopkins syndrome
  • Schizophrenia
  • Transcription

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology

Fingerprint

Dive into the research topics of 'The emerging roles of TCF4 in disease and development'. Together they form a unique fingerprint.

Cite this